Adam Logal
Directeur Financier/CFO chez OPKO HEALTH, INC.
Fortune : 223 955 $ au 30/06/2024
Profil
Adam E.
Logal is currently the Chairman at Xenetic Biosciences, Inc. since 2017.
He is also currently serving as the Director at Bio-Reference Laboratories, Inc. since 2015, the Director at OPKO Biologics Ltd.
since 2014, and the CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2007.
Formerly, Mr. Logal served as the Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007.
He was also a Director at SciVac Therapeutics, Inc. Additionally, he held the position of Independent Director at VBI Vaccines, Inc. from 2015 to 2018.
Prior to that, he was the Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007.
Lastly, he served as the President at GeneDx LLC in 2020 and 2021.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPKO HEALTH, INC.
0,03% | 29/02/2024 | 179 164 ( 0,03% ) | 223 955 $ | 30/06/2024 |
| 31/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Adam Logal
| Sociétés | Poste | Début |
|---|---|---|
| OPKO HEALTH, INC. | Directeur Financier/CFO | 31/03/2014 |
| BIO-REFERENCE LABORATORIES INC | Directeur/Membre du Conseil | 20/08/2015 |
| XENETIC BIOSCIENCES, INC. | Président | 14/08/2017 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Directeur/Membre du Conseil | 01/04/2014 |
Anciens postes connus de Adam Logal
| Sociétés | Poste | Fin |
|---|---|---|
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a private company that provides genomic testing services. The company is based in Stamford, CT. The company was founded in 2000. Katherine A. Stueland has been the CEO of the company since 2021. | President | 01/06/2021 |
| VBI VACCINES INC. | Directeur/Membre du Conseil | 01/10/2018 |
| eXegenics, Inc. | Directeur Financier/CFO | 13/06/2007 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Directeur Financier/CFO | 01/01/2007 |
| SciVac Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| OPKO HEALTH, INC. | Health Services |
| VBI VACCINES INC. | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
| eXegenics, Inc. | Health Technology |
Bio-Reference Laboratories, Inc.
 Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
| SciVac Therapeutics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a private company that provides genomic testing services. The company is based in Stamford, CT. The company was founded in 2000. Katherine A. Stueland has been the CEO of the company since 2021. | Health Services |
